Alibaba Gains on AI Glasses; Liquidia Surges Post-Settlement

By EC Assets · Published 14 October 2026

Alibaba Group Holding stock gained in premarket trading on Wednesday following news of new AI glasses. Liquidia Corp shares also surged premarket. This movement occurred as stock index futures were higher. Liquidia shares surged after the biotechnology company reached a global settlement with United Therapeutics. This resolution addresses years of litigation between the two firms. Liquidia (LQDA) ended all six pending lawsuits with United Therapeutics (UTHR) late on Tuesday. The settlement totals $380.7 million and allows Liquidia to keep its Yutrepia treatment for pulmonary arterial hypertension on the market. Previously, Liquidia shares had plunged over 60% due to a major patent setback related to Yutrepia. The United Therapeutics patent suit had been a pending issue. Liquidia had reported on Yutrepia's launch economics while this suit was still active. Stock index futures were generally higher on Wednesday. Dow Jones, S&P 500, and Nasdaq 100 futures all rose. This followed a Tuesday session where U.S. stocks closed lower. Traders focused on the consumer inflation report. This article is intended for informational purposes only. It does not constitute investment advice.